Related Experiment Video
Updated: Aug 12, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Apurinic sites are position-specific topoisomerase II poisons
1Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, USA.
Abstract:
Many anticancer drugs "poison" topoisomerase II by enhancing its double-stranded DNA cleavage activity. To determine whether DNA lesions act as endogenous topoisomerase II poisons, we characterized the effects of position-specific apurinic sites on enzyme activity. Lesions located within the 4-base overhang generated by enzyme-mediated DNA scission stimulated cleavage approximately 10-18-fold without altering the specificity of topoisomerase II. DNA breaks were double-stranded in nature, protein-linked, and readily reversible. In contrast, apurinic sites located immediately outside the cleavage overhang were inhibitory. Thus, apurinic sites, which are the most commonly formed lesion in DNA, are position-specific topoisomerase II poisons. A model is proposed that encompasses the actions of endogenous and exogenous topoisomerase II poisons and provides a pre-existing pathway for the cellular actions of topoisomerase II-targeted anticancer drugs.
Insights
DNA lesions, specifically apurinic sites, act as endogenous topoisomerase II poisons. These DNA lesions enhance DNA cleavage activity, impacting anticancer drug mechanisms.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Topoisomerase II is a crucial enzyme for DNA replication and repair.
- Many anticancer drugs function by "poisoning" topoisomerase II, increasing its DNA-cleavage activity.
- Endogenous DNA lesions may also influence topoisomerase II activity.
Purpose of the Study:
- To investigate whether apurinic sites, a common DNA lesion, function as endogenous topoisomerase II poisons.
- To characterize the impact of the position of apurinic sites on topoisomerase II activity.
Main Methods:
- Site-specific introduction of apurinic sites into DNA substrates.
- Biochemical assays to measure topoisomerase II-mediated DNA cleavage.
- Analysis of DNA cleavage products and enzyme kinetics.
Main Results:
- Apurinic sites located within the 4-base overhang of DNA scission stimulated topoisomerase II cleavage 10-18 fold.
- The specificity of topoisomerase II was not altered by these lesions.
- Apurinic sites outside the cleavage overhang inhibited enzyme activity.
- The DNA breaks generated were double-stranded, protein-linked, and reversible.
Conclusions:
- Apurinic sites function as position-specific poisons of topoisomerase II.
- This finding provides a mechanism for how endogenous DNA damage influences topoisomerase II.
- A unifying model for endogenous and exogenous topoisomerase II poisons is proposed, relevant to anticancer drug action.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
10:13Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Drugs that Destabilize Microtubules
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Pharmaceutical Poisoning: Treatment Strategies
Inhibitors of Bacterial DNA Synthesis